Treatment modalities for autoimmune diseases
US7718198B2 · kind B2 · utility
3Cited by
45References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2006 |
| Grant date | May 18, 2010 |
| Priority date | — |
| Expiry date | Mar 25, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.